Breaux v. Novo Nordisk Inc et al
| Rhonda Breaux |
| Novo Nordisk Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Research Center Seattle Inc, Novo Nordisk Pharmaceutical Industries L P and Novo Nordisk A/S |
| 2:2023cv01365 |
| September 29, 2023 |
| US District Court for the Western District of Louisiana |
| James D Cain |
| Kathleen Kay |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-(Citizenship) |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 12, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 23 NOTICE of Motion Setting without oral argument regarding: #22 MOTION to Dismiss For Failure to State a Claim. Motion day set for 12/27/2023 before Judge James D Cain Jr. (crt,Thomas, T) |
| Filing 22 MOTION to Dismiss For Failure to State a Claim by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (Attachments: #1 Memorandum / Brief Memo in Support of MTD, #2 Affidavit Declaration of Diana Surprenant, #3 Exhibit 1 - 2017 Ozempic Label, #4 Exhibit 2 - 2020 Ozempic Label, #5 Exhibit 3 (Part 1 of 3) - CDER Clinical Review Ozempic Nov. 2017., #6 Exhibit 3 (Part 2 of 3) - CDER Clinical Review Ozempic Nov. 2017, #7 Exhibit 3 (Part 3 of 3) - CDER Clinical Review Ozempic Nov. 2017, #8 Exhibit 4 - 2022 Ozempic Label)(aty,Surprenant, Diana) Modified text on 11/14/2023 (Thomas, T). |
Filing 21
ORDER: As discussed in the Rule 16 conference held on November 7, 2023, the jury trial in this matter is hereby set to begin on September 14, 2026, and will continue through October 9, 2026. Signed by Judge James D Cain, Jr on 11/7/2023. (crt,Thomas, T)
|
|
Filing 20
ORDER: As discussed in the Rule 16 conference held on November 7, 2023, the parties are hereby ORDERED to submit a joint proposed scheduling order/discovery plan and a proposed order for the preservation of electronically stored information to the court by December 19, 2023. Signed by Judge James D Cain, Jr on 11/7/2023. (crt,Thomas, T)
|
| Filing 19 MINUTES for proceedings held before Judge James D Cain, Jr: SCHEDULING CONFERENCE held on 11/7/2023 pursuant to Federal Rule of Civil Procedure 16. The court and counsel discussed anticipated scheduling issues due to the anticipated complexity of the case. Separate orders will be docketed setting a jury trial and deadlines. (crt,Stewart, T) |
| Filing 18 Joint RULE 26(f) Report by Rhonda Breaux, Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (aty,Brown, Somer) Modified to add filers on 11/1/2023 (Thomas, T). |
|
Filing 17
ORDER granting #16 Motion to Appear Pro Hac Vice for appearance of Loren H Brown for Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Signed by Magistrate Judge Kathleen Kay on 10/23/2023. (crt,Thomas, T)
|
| Filing 16 MOTION for Loren H. Brown to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5731397) by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/19/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Surprenant, Diana) |
| Filing 15 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (aty,Surprenant, Diana) |
| Filing 14 CORPORATE DISCLOSURE STATEMENT by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc identifying Corporate Parent Novo Nordisk U S Research Investment Holdings Inc for Novo Nordisk Research Center Seattle Inc; Corporate Parent Novo Nordisk U S Commercial Holdings Inc for Novo Nordisk Inc; Corporate Parent Novo Nordisk A/S for Novo Nordisk U S Holdings Inc; Corporate Parent Novo Nordisk U S Manufacturing Holdings Inc for Novo Nordisk Pharmaceutical Industries L P; Corporate Parent Novo Nordisk U S Holdings Inc for Novo Nordisk U S Commercial Holdings Inc. (aty,Surprenant, Diana) |
|
Filing 13
ELECTRONIC ORDER granting #11 Consent MOTION for Extension of Time to File Answer re #1 Complaint: Answer due date reset to 11/14/2023. Signed by Judge James D Cain, Jr on 10/19/2023. (crt,Higgins, M)
|
|
Filing 12
ELECTRONIC ORDER REFERRING MOTION: #11 Consent MOTION for Extension of Time to File Answer re #1 Complaint, filed by Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc, Novo Nordisk Inc Motions referred to Judge James D Cain, Jr. Signed by Judge James D Cain, Jr on 10/10/2023. (crt,Higgins, M)
|
| Filing 11 Consent MOTION for Extension of Time to File Answer re #1 Complaint, by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/9/2023. (Attachments: #1 Proposed order)(Attorney Diana Cole Surprenant added to party Novo Nordisk Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk Pharmaceutical Industries L P(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk Research Center Seattle Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk U S Commercial Holdings Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk U S Holdings Inc(pty:dft))(aty,Surprenant, Diana) |
|
Filing 10
ELECTRONIC ORDER: A Rule 16 conference is set for 11/7/2023 at 10:30 AM by phone before Judge Cain. Counsel shall use the chambers teleconference line at (877) 873-8018, Access Code: 4800394. Signed by Judge James D Cain, Jr on 10/3/2023. (crt,Higgins, M)
|
| Filing 9 AFFIDAVIT of Service for Complaint served on Novo Nordisk Research Center Seattle Inc on 10/3/2023, filed by Rhonda Breaux. Answer due 10/24/2023. (aty,Cox, Michael) Modified to add answer due date on 10/3/2023 (Thomas, T). |
| Filing 8 AFFIDAVIT of Service for Complaint served on Novo Nordisk US Commerical Holdings Inc on 10/3/2023, filed by Rhonda Breaux. Answer due 10/24/2023. (aty,Cox, Michael) Modified to add answer due date on 10/3/2023 (Thomas, T). |
| Filing 7 AFFIDAVIT of Service for Complaint served on Novo Nordisk Pharmaceutical Industries LP on 10/3/2023, filed by Rhonda Breaux. Answer due 10/24/2023. (aty,Cox, Michael) Modified to add answer due date on 10/3/2023 (Thomas, T). |
| Filing 6 AFFIDAVIT of Service for Complaint served on Novo Nordisk Inc on 10/3/2023, filed by Rhonda Breaux. Answer due 10/24/2023. (aty,Cox, Michael) Modified to add answer due date on 10/3/2023 (Thomas, T). |
| Filing 5 AFFIDAVIT of Service for Complaint served on Novo Nordisk US Holdings Inc on 10/3/2023, filed by Rhonda Breaux. Answer due 10/24/2023. (aty,Cox, Michael) Modified to add answer due date on 10/3/2023 (Thomas, T). |
| Filing 4 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Rhonda Breaux. (aty,Cox, Michael) |
| Filing 3 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #1 Complaint, sent to Michael K Cox on behalf of Rhonda Breaux. Diversity Jurisdiction Disclosure Statement due by 10/16/2023. (crt,Thomas, T) |
| Filing 2 SUMMONS ISSUED as to Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Thomas, T) |
| CASE Assigned to Judge James D Cain, Jr and Magistrate Judge Kathleen Kay. (crt,Thomas, T) |
| Filing 1 COMPLAINT against Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc with Jury Demand (Filing fee $402, receipt number ALAWDC-5709437) filed by Rhonda Breaux. (Attachments: #1 Civil cover sheet)(Attorney Michael K Cox added to party Rhonda Breaux(pty:pla))(aty,Cox, Michael) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Louisiana Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
